Vimarsana
Biggest News Aggregation in the World

Page 5 - Jonathan Graham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Graham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Graham Today - Breaking & Trending Today

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies - Vimarsana News

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat...

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies - Vimarsana News

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reaction The US FDA recently approved Xolair as the first and only medicine for children and adults with one or […]

FDA approves Xolair® (omalizumab) as first and only medicine for children and adults with one or more food allergies - Vimarsana News

FDA approves Xolair® (omalizumab) as first and only medicine for children and adults with one or more food allergies

Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as...

Freeport of Monrovia documentary premiered - Liberia news The New Dawn Liberia, premier resource for latest news - Vimarsana News

Freeport of Monrovia documentary premiered - Liberia news The New Dawn Liberia, premier resource for latest news

A documentary produced by Mr. Jonathan Graham, outgoing Managing Director of AMP Terminal about the Freeport of Monrovia was premiered last Friday at the Ministerial Complex in Monrovia.

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors - Vimarsana News

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs. 8.5 months with high-dose octreotide LAR in patients with newly diagnosed grade 2...